Navigation Links
Researchers Report First Successful Treatment of Chronic Traumatic Brain Injury
Date:10/11/2007

ARLINGTON, Va., Oct. 11 /PRNewswire/ -- The American Association of Health Freedom and the International Hyperbaric Medical Association announced today that physician-researchers at the Baromedical Research Institute and Louisiana State University School of Medicine, New Orleans have reported the successful treatment of chronic traumatic brain injury (TBI). The findings, published in Brain Research (2007 Oct 12;1174:120-9), are purportedly the first-ever demonstration of improvement of chronic brain injury in animals. The treatment involved a new application and drug dosage of hyperbaric oxygen therapy. Hyperbaric oxygen therapy has been applied to diving injuries, carbon monoxide poisoning, "flesh-eating bacteria," and chronic wounds. Application to chronic brain injury is controversial. This demonstration is a landmark achievement that reverses 100 years of neurology and the institutionalized belief that chronic brain injury in untreatable. It has significant implications for the treatment of chronic human traumatic brain injury (TBI) such as for current U.S. military veterans.

Lead author, Paul G. Harch, M.D., Clinical Assistant Professor, Director of the LSU School of Medicine Hyperbaric Medicine Fellowship in New Orleans, and author of recently published The Oxygen Revolution (Hatherleigh Press, NY), said that he made this discovery when he first applied HBOT to divers with a disabling form of "the bends," brain decompression illness. Harch noticed that the traditional application of a single HBOT to freshly injured divers did not result in the immediate cure described by the U.S. Navy. Instead, divers from the Gulf of Mexico presented days to weeks after their injury and required much more HBOT at a lower pressure. Eventually, he realized that they were treating more chronic forms of brain injury since the bubbles had long passed through the divers' brains. Harch and colleagues applied this lower dose of HBOT to patients with other forms of chroni
'/>"/>

SOURCE American Association of Health Freedom
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. NIEHS Researchers Identify Enzyme Critical in DNA Replication
2. Stanford Researchers Find Brain Pathway of Depression in Rats
3. Researchers Discover Method for Identifying How Cancer Evades the Immune System
4. Researchers Discover Gene For Rare Skin Disorder
5. Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action
6. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
7. Stanford Researchers Track Human Stem Cells Transplanted Into Rat Brain
8. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
9. World First Medical Treatment Announced by Researchers at Queen Mary University London and University of Leicester
10. Researchers Urge Caution in Using ESAs for Cancer-Related Anemia
11. Researchers Identify New Genetic Risk Factors for Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , Safinamide significantly improves ... as add-on to levodopa Safinamide is ... in fluctuating PD patients as add-on to levodopa ... ("Newron"), a research and development company focused on ... Zambon S.p.A., a pharmaceutical company strongly committed to ...
(Date:6/18/2013)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... VPII Escrow Corp., a newly formed wholly owned Canadian ... approximately $3.2 billion aggregate principal amount of senior unsecured ... 2021 and in 2023, with final tranching determined at ... net proceeds from the offering, together with proceeds from ...
(Date:6/18/2013)... 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT ... development and commercialization of novel bile acid therapeutics to ... an underwritten public offering of 1,730,000 shares of its ... per share.  In addition, Intercept has granted the underwriters ... 259,500 shares of common stock. All of ...
Breaking Medicine Technology:Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
...  GenVec, Inc. (Nasdaq: GNVC ) will report financial ... 2011 on Thursday, March 15, 2012, before the U.S. financial ... and conference call at 10:00 a.m. EDT to discuss the ... outlook. To listen to the live conference ...
... release of System 7 – the next generation of heavy ... such as hip and knee replacements. System 7 offers the ... and highest performing power tool system ever from Stryker. ... heavy duty power tools in 1982, and has built a ...
Cached Medicine Technology:GenVec to Release Fourth Quarter and Year-End 2011 Financial Results and Conduct a Conference Call on March 15, 2012 2Stryker Launches Next Generation Heavy Duty Surgical Power Tools 2
(Date:6/18/2013)... (PRWEB) June 19, 2013 Looking for a ... monotony of everyday life? , IWALKAWAKE is a guide ... Written by Adam Botha, it focuses on harnessing the powerful ... The book lays out a nine-step guide to finding one’s ... that a person must go through to reach their true ...
(Date:6/18/2013)... Daily Gossip Magazine has always kept its readers entertained ... , The magazine has decided to prepare readers for the ... recipe every week . , According to Daily Gossip ... readers who are looking to get insights into this type ... anabolic food is almost entirely based on healthy, yet tasteful ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 SEATTLE, WA—A ... Farms of Fairview, Oregon, claiming he fell ill with ... berry and pomegranate seed blend. The complaint was ... by Marler Clark, the Seattle-based law firm that has ... , According to the complaint, Brian Brothers consumed “Townsend ...
(Date:6/18/2013)... Warner, NH (PRWEB) June 18, 2013 ... rugged, submersible, battery powered, stand-alone device which can be ... The new stainless steel enclosure of the Temp1000IS comes ... device interfaces with the IFC400 (sold separately) ... docking station for full communications. No more removal of ...
(Date:6/18/2013)... Senior drug regulatory officials from mainland China and Taiwan ... first time in the U.S.—the need for more collaboration between ... in a timely manner. Representatives from the Taiwan and mainland ... and processes in drug review during the Convergence in ... DIA 2013 49th Annual Meeting . , While ...
Breaking Medicine News(10 mins):Health News:Anabolic Cooking Book Review Exposes Dave Ruel’s Top 10 ‘Anabolicious’ Recipes for BodyBuilders 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 3Health News:MadgeTech, Inc. Introduces the New Temp1000IS Intrinsically Safe High Temperature Data Logger 2Health News:Renowned Regulatory Representatives From Mainland China and Taiwan to Discuss Need for Collaboration at DIA Meeting 2
... EVVV ),a global endovascular device company, today ... and Chief Financial Officer, effective January,19, 2009. Mr. ... President and Chief Financial Officer effective January 19, 2009. ... than 15 years of experience in the medical,device industry ...
... a flatter, tighter stomachSHELBY TOWNSHIP, Mich., Jan. 9 ... tummy tuck without the downtime!The traditional tummy tuck, or ... want to regain a flat stomach after weight fluctuations ... solves the problem of the loose abdominal skin and ...
... trends and growth predictions of industry.NEW YORK, Jan. 9 ... and the Advanced Medical Technology Association (AdvaMed) today announced ... industry experts on the major trends and growth in ... survey aims to generate new data points on geography, ...
... also rule out this additional measure, study suggests , , ... levels in an asthmatic child,s breath every day does ... a new study shows. , Nitric oxide (NO) amounts ... symptoms or even an attack. But a 30-week Dutch ...
... Jan. 9 A study published today in The,Journal ... the mean annual price tag for lupus - including ... - was,nearly $20,000 per patient. The mean cost climbed ... by the kidney disease nephritis, as it,often is. That,s ...
... kids in five-county regionPHILADELPHIA, Jan. 9 An inherent ... more opportunities and a better life than their parents ... obesity among children continues to rise, and the current ... country,s history to have a shorter lifespan than their ...
Cached Medicine News:Health News:ev3 Inc. Appoints Shawn McCormick as New Sr. Vice President and Chief Financial Officer 2Health News:Doctors at Allure Medical Spa Are Getting the Results of a Tummy Tuck Without the Downtime 2Health News:Gerson Lehrman Group Partners With AdvaMed for Survey on Medical Device Industry 2Health News:Gerson Lehrman Group Partners With AdvaMed for Survey on Medical Device Industry 3Health News:Nitric Oxide Monitoring of Little Benefit for Kids' Asthma 2Health News:Lupus is a Significant Cost to Employers, According to Thomson Reuters Study 2Health News:Lupus is a Significant Cost to Employers, According to Thomson Reuters Study 3Health News:The Archdiocese of Philadelphia and Independence Blue Cross Team Up to Address Childhood Obesity 2Health News:The Archdiocese of Philadelphia and Independence Blue Cross Team Up to Address Childhood Obesity 3Health News:The Archdiocese of Philadelphia and Independence Blue Cross Team Up to Address Childhood Obesity 4
Inquire...
This fixed-volume digital micropipet is used to accurately measure and transfer 20 microliters of solution....
20L...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Medicine Products: